Journal Home
Search for

Volume 61, Issue 6, Pages 945-958 (December 2009)


View previous. 9 of 51 View next.

Angiogenesis in cutaneous disease: Part II

Vivian Laquer, BSa, Van Hoang, BSc, Amy Nguyen, MDb, Kristen M. Kelly, MDbcCorresponding Author Informationemail address

This review will discuss the role of angiogenesis in specific cutaneous diseases. Scientific evidence now points to the role of angiogenesis in tumor development and many other cutaneous disorders. Angiogenesis is a complex process that involves angiogenic growth factors and inhibitors, many of which could be a potential target for pharmacologic intervention. Antiangiogenic agents have recently been applied to dermatologic diseases with promising efficacy.

Learning objectives

After completing this learning activity, participants should be able to recognize cutaneous diseases where angiogenesis is likely to be an important factor, recognize scenarios where angiogenic therapy may be useful in conjunction with traditional therapies, and be able to use angiogenic-mediating agents in the treatment of dermatologic disease.

a Columbia University College of Physicians, New York, New York

b Department of Dermatology, University of California, Irvine, California

c University of California Irvine College of Medicine, Irvine, California

Corresponding Author InformationCorrespondence to: Kristen Kelly, MD, Department of Dermatology, University of California, Irvine, 1002 Health Sciences Rd, Irvine, CA 92612.

 Funding sources: None.

 Conflicts of interest: The authors, editors, and peer reviewers have no relevant financial relationships.

 Reprints not available from the authors.

PII: S0190-9622(09)00943-8

doi:10.1016/j.jaad.2009.05.053


View previous. 9 of 51 View next.